Stocks · Industrials · Services-Testing Laboratories

NEOGENOMICS INC

NEO Clue Score37
United States Fiscal year ends December CIK 0001077183 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Anthony P. Zook
6 Aug 2025
Chief Executive Officer
Buy
17,900
$5.58
$99.95K
Jeffrey Scott Sherman
6 Aug 2025
Chief Financial Officer
Buy
20,000
$5.62
$112.32K
Michael Aaron Kelly
27 May 2025
Director
Buy indirect
5,000
$7.60
$38.00K
Warren Stone
12 May 2025
Pres & Chief Operating Officer
Buy
5,700
$8.58
$48.89K
Lynn A. Tetrault
9 May 2025
Director
Buy indirect
7,000
$8.14
$56.97K
Stephen M Kanovsky
7 May 2025
Director
Buy
4,000
$7.78
$31.12K
Anthony P. Zook
6 May 2025
Chief Executive Officer
Buy indirect
18,900
$7.88
$148.92K
Neil Gunn
5 May 2025
Director
Buy
4,510
$7.76
$34.98K
David Brian Perez
5 May 2025
Director
Buy indirect
10,000
$7.63
$76.30K
Jeffrey Scott Sherman
2 May 2025
Chief Financial Officer
Buy
20,000
$7.51
$150.10K
Mark Mallon
6 Dec 2021
Chief Executive Officer
Buy
17,000
$30.63
$520.71K
Kevin C Johnson
21 Dec 2018
Director
Buy
26,000
$11.60
$301.60K
Alison L. Hannah
27 Jul 2017
Director
Buy
20,000
$9.19
$183.80K

What was left out

Form 4 filings counted 395
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 43
Sales at will 87
Transactions with no price 0
Shares from compensation/vesting 9,474,898
Sales filed before the plan box existed 86
History held since 9 May 2011